Scratch Out This Weed Stock From Your Shopping List

Just like industry peers, CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) reported impressive revenue growth but disappointing bottom-line results. The stock recently tumbled and might remain in negative territory unless profitability improves.

Economic Turbulence

Image source: Getty Images

The anxiety of investors in the cannabis space heightens every time a sordid tale about a cannabis company comes out. On March 28, it was the turn of CannTrust Holdings (TSX:TRST)(NYSE:CTST) to report Q4 2018 and full-year earnings. While the both the top-line and year-over-year growth were impressive, the stock still fell 18.95%.

CannTrust’s sales growth is stellar but is analogous to the situation of the bigger industry players. Again, investors are frustrated about the bottom line, which is the real gauge of performance. The fourth-quarter sales growth yielded a net loss of $25.5 million and a dismal $6.2 million net income. The saga of discontent continues.

Eroding gross margins

Investor confidence in the cannabis sector continues to erode. You can’t blame others who see weed stocks as nothing more than a pump-and-dump play. While nearly all cannabis producers reported astronomical growth sales, losses are enormous as well. There’s still no solid business case at the start of Q2 2019.

On a full-year basis, CannTrust’s net loss amounted to $13.5 million versus a $6.8 million net income in 2017. In terms of EPS, the company reported a loss per share of $0.26 in the fourth quarter compared to $0.08 for the same period in 2017. Judging by the reported earnings of industry peers, the losses were somewhat expected.

The declining gross margin is adding insult to injury. CannTrust’s gross margins in the fourth quarter barely improved (34% to 35%) from a year ago. But on a full-year basis, the 6% contraction in gross margins (from 63% to 57%) was quite telling. CannTrust’s cash cost per gram fell sharply from $5.16 in Q4 2017 to $2.94 in Q4 2018.

On the wholesale side, which includes recreational cannabis, CannTrust sold about 1.2 million grams of dried cannabis during the fourth quarter and extracts of about 104 thousand grams. For the first time, the wholesale segment brought in sales Q1 2019. Dried cannabis and extracts were sold for $4.20 and $3.90 per gram, respectively.

But pricing can become a major factor in the future. The only way to achieve economies of scale is to double or triple production capacity, which the company is currently working on.

Across the border, investors also punished the stock of the newly listed weed company on the NYSE. The erosion in gross margin didn’t sit well with them despite the revenues doubling year over year.

Not a strong buy

Back home, there are bullish sentiments. Some analysts see a potential +29.07% increase to $12.74. The recommendation trend is a buy but not a strong buy. The current price is at par with its 200-day moving average of $9.94. However, blowing past the 50-day moving average of $11.72 might be a struggle.

Caution is advised as the cannabis sector appears more volatile than the general market. As for CannTrust, profitability can come sometime late 2020 when peak annual output reaches 200,000 kilos. Thus, be circumspect and scratch out the stock from your shopping list for now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »